Evaluation of connectivity map shows limited reproducibility in drug repositioning
Abstract The Connectivity Map (CMap) is a popular resource designed for data-driven drug repositioning using a large transcriptomic compendium. However, evaluations of its performance are limited. We used two iterations of CMap (CMap 1 and 2) to assess their comparability and reliability. We queried...
Guardado en:
Autores principales: | Nathaniel Lim, Paul Pavlidis |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9e2c9782c48e4f3c8dd4b0ba6b14221c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Enriching limited information on rare diseases from heterogeneous networks for drug repositioning
por: Hongkui Cao, et al.
Publicado: (2021) -
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro.
por: Nichole Orr-Burks, et al.
Publicado: (2021) -
Drug repositioning by merging active subnetworks validated in cancer and COVID-19
por: Marta Lucchetta, et al.
Publicado: (2021) -
Transcriptional drug repositioning and cheminformatics approach for differentiation therapy of leukaemia cells
por: Yasaman KalantarMotamedi, et al.
Publicado: (2021) -
Drug repositioning of Clopidogrel or Triamterene to inhibit influenza virus replication in vitro
por: Nichole Orr-Burks, et al.
Publicado: (2021)